全文获取类型
收费全文 | 10067篇 |
免费 | 32篇 |
国内免费 | 9篇 |
专业分类
电工技术 | 65篇 |
综合类 | 3篇 |
化学工业 | 676篇 |
金属工艺 | 270篇 |
机械仪表 | 227篇 |
建筑科学 | 26篇 |
矿业工程 | 80篇 |
能源动力 | 21篇 |
轻工业 | 70篇 |
水利工程 | 72篇 |
石油天然气 | 200篇 |
无线电 | 400篇 |
一般工业技术 | 1058篇 |
冶金工业 | 6358篇 |
原子能技术 | 396篇 |
自动化技术 | 186篇 |
出版年
2022年 | 47篇 |
2021年 | 70篇 |
2020年 | 48篇 |
2019年 | 51篇 |
2018年 | 128篇 |
2017年 | 139篇 |
2016年 | 171篇 |
2015年 | 63篇 |
2014年 | 104篇 |
2013年 | 150篇 |
2012年 | 146篇 |
2011年 | 165篇 |
2010年 | 135篇 |
2009年 | 158篇 |
2008年 | 150篇 |
2007年 | 144篇 |
2006年 | 108篇 |
2005年 | 102篇 |
2004年 | 83篇 |
2003年 | 91篇 |
2002年 | 83篇 |
2001年 | 69篇 |
2000年 | 74篇 |
1999年 | 254篇 |
1998年 | 2006篇 |
1997年 | 1170篇 |
1996年 | 766篇 |
1995年 | 450篇 |
1994年 | 321篇 |
1993年 | 416篇 |
1992年 | 84篇 |
1991年 | 93篇 |
1990年 | 103篇 |
1989年 | 91篇 |
1988年 | 72篇 |
1987年 | 71篇 |
1986年 | 80篇 |
1985年 | 75篇 |
1983年 | 61篇 |
1982年 | 67篇 |
1981年 | 92篇 |
1980年 | 96篇 |
1979年 | 49篇 |
1978年 | 88篇 |
1977年 | 193篇 |
1976年 | 371篇 |
1975年 | 65篇 |
1974年 | 53篇 |
1973年 | 50篇 |
1972年 | 45篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
951.
952.
T Peelen M van Vliet A Petrij-Bosch R Mieremet C Szabo AM van den Ouweland F Hogervorst R Brohet MJ Ligtenberg E Teugels R van der Luijt AH van der Hout JJ Gille G Pals I Jedema R Olmer I van Leeuwen B Newman M Plandsoen M van der Est G Brink S Hageman PJ Arts MM Bakker P Devilee 《Canadian Metallurgical Quarterly》1997,60(5):1041-1049
We have identified 79 mutations in BRCA1 in a set of 643 Dutch and 23 Belgian hereditary breast and ovarian cancer families collected either for research or for clinical diagnostic purposes. Twenty-eight distinct mutations have been observed, 18 of them not previously reported and 12 of them occurring more than once. Most conspicuously, a 2804delAA mutation has been found 19 times and has never been reported outside the Netherlands. A common haplotype spanning > or = 375 kb could be identified for each of the nine examined recurrent mutations, indicating the presence of multiple BRCA1 founder mutations in the Dutch population. The 2804delAA mutation has been estimated to have originated approximately 32 generations ago. No specific breast or ovarian cancer phenotype could be assigned to any of the common mutations, and the ovarian cancer incidence among 18 families with the 2804delAA mutation was heterogeneous. 相似文献
953.
The n-type thermoelectric Bi1.9Lu0.1Te3 was prepared by microwave-solvothermal method and spark plasma sintering. The magnetic field and temperature dependences of transverse magnetoresistance measured within temperature 2–200 K interval allow finding the peculiarities characteristic for strongly disordered and inhomogeneous semiconductors. The first peculiarity is due to appearance of linear-in-magnetic field contribution to the total magnetoresistance reflected in a crossover from quadratic magnetoresistance at low magnetic fields to linear magnetoresistance at high magnetic fields. The linear magnetoresistance can result from the Hall resistance picked up from macroscopically distorted current paths due to local variations in stoichiometry of the compound studied. The second peculiarity is that both linear magnetoresistance magnitude and crossover field are functions of carrier mobility which is in agreement with the Parish and Littlewood model developed for disordered and inhomogeneous semiconductors. An increase in the mobility due to a decrease in temperature is accompanied by an increase in the magnetoresistance magnitude and a decrease in the crossover field. Finally, the third peculiarity is related to the remarkable deviation of the total magnetoresistance measured at various temperatures from the Kohler's rule. Presence of strong inhomogeneity and disorder in the Bi1.9Lu0.1Te3 structure concluded from the magnetoresistance peculiarities can be responsible for the remarkable reduction in the total thermal conductivity of this compound. 相似文献
954.
Amplification of a 340 bp sequence of the 38 kDa protein gene of Mycobacterium tuberculosis by the polymerase chain reaction has been developed. The sensitivity of this PCR was shown to be 10 fg both by agarose gel electrophoresis and Southern blot hybridisation being equivalent to 2-3 organisms and highly specific to M. tuberculosis and excluding even M. tuberculosis H37Ra and Mycobacterium bovis BCG. Sputum samples from patients with pulmonary tuberculosis gave a positivity rate of 45%. PCR was also performed using pt8 and pt9 primers which amplified a 541 bp sequence of IS6110. 41% of the above samples gave positive amplification. Three samples that were positive for 38 kDa sequence were negative for IS6110. 相似文献
955.
MJ de Gortari BA Freking SM Kappes KA Leymaster AM Crawford RT Stone CW Beattie 《Canadian Metallurgical Quarterly》1997,28(4):274-290
We report the evaluation of 1036 bovine microsatellite primer pairs for their suitability as linkage markers in sheep. Approximately 58% (605/1036) of bovine primer pairs amplified a locus in sheep. Sixty-seven per cent (409/605) of amplified loci were detected as polymorphic. Marker heterozygosity, allele number and range of allele sizes were significantly lower in sheep than cattle sampled in this study. However, median fragment size was similar. These data suggest that high-resolution comparative linkage maps between closely related species can be constructed relatively efficiently. 相似文献
956.
957.
958.
BACKGROUND: The rationale for the study was based on the hypothesis that decreased or absent expression on tumor cells of adhesion molecules, the class I or class II major histocompatibility complex (MHC) molecules, or costimulatory molecules might be responsible, in part, for the poor ability of squamous cell carcinoma of the head and neck (SCCHN) to induce generation of antitumor effector cells in vitro and in vivo. OBJECTIVE: To investigate expression of intercellular adhesion molecule-1 (ICAM-1) and lymphocyte function associated antigen-3 (LFA-3) and distribution of the costimulatory molecules, B7.1, B7.2, and CD40, and of class I and class II MHC molecules on SCCHN cells in situ and on SCCHN cell lines. SETTING: University medical centers. DESIGN: Expression of ICAM-1, LFA-3, MHC molecules, B7.1, B7.2, and CD40 was evaluated in human SCCHN biopsy specimens by immunohistochemistry and on SCCHN cell lines by flow cytometry. To confirm our hypothesis that impaired T-cell activation observed in patients with SCCHN is caused by the absence of costimulatory B7 molecules, a B7-negative SCCHN cell line was transduced with the B7.1 gene, using a retroviral vector, and tested in mixed lymphocyte tumor cocultures. RESULTS: In contrast to abundant expression of ICAM-1, LFA-3, class I MHC molecules, and CD40, the absence of B7.1, B7.2, and class II MHC molecules on tumor cells was observed in situ and in vitro. Lymphocytes and antigen-presenting cells in inflammatory infiltrates surrounding tumor cell clusters expressed both costimulatory and adhesion molecules. The SCCHN lines negative for B7.1 and class II MHC antigens failed to induce proliferation of T cells in mixed lymphocyte tumor cocultures. However, when these cell lines were transduced with the B7.1 gene, their ability to induce T-cell proliferation in mixed lymphocyte tumor cocultures was restored. CONCLUSIONS: The absence of B7 protein or class II MHC antigen expression on human SCCHN cells is responsible for the failure of these tumors to induce proliferation of T cells in vitro. Transduction of the B7.1 gene into SCCHN restores the ability of the tumor to induce T-cell proliferation in vitro. 相似文献
959.
960.
JG Liese CK Meschievitz E Harzer J Froeschle P Hosbach JE Hoppe F Porter S Stojanov K Niinivaara AM Walker BH Belohradsky 《Canadian Metallurgical Quarterly》1997,16(11):1038-1044
OBJECTIVE: This case-control study investigated the protective efficacy against pertussis of three doses of a two-component acellular pertussis vaccine (manufactured by Biken in Japan) combined with diphtheria and tetanus toxoids (manufactured by Connaught Laboratories in the US) in infants. METHODS: A case-control study was performed in 63 pediatric practices in Germany. Prospective recruitment of 16,780 infants ages 6 to 17 weeks took place between February, 1993, and July, 1994. According to parental choice infants received either Biken acellular pertussis vaccine combined with diphtheria and tetanus toxoids (DTacP) (74.6%) at approximately 2, 4 and 6 months of age, or a licensed German diphtheria-tetanus toxoids-whole cell pertussis vaccine (10.9%), diphtheria-tetanus toxoids vaccine (12.5%) or no vaccine (2.0%). Prospective surveillance of pertussis cases between February, 1993, and May, 1995, was accomplished by culturing all infants < or =2 years of age presenting with cough > or = 7 days. A pertussis case was defined as any cough of 21 days or longer plus a positive Bordetella pertussis culture or household contact exposure. RESULTS: We identified 241 pertussis cases prospectively by 11,017 B. pertussis cultures and 949 controls matched for age were selected from the same pediatric practices. Medical history and demographic and vaccine status data were collected from each case and for four controls. Data were analyzed through conditional logistic regression taking into account individual matching and adjusting for potential confounding variables. DTacP combined with diphtheria and tetanus toxoids vaccine was 82% protective (95% confidence interval, 68 to 90), diphtheria-tetanus toxoids-whole cell pertussis vaccine was 96% protective (95% confidence interval, 78 to 99). Protection against typical B. pertussis infection characterized by paroxysmal cough lasting > or =21 days was 96% (95% confidence interval, 87 to 99) for DTacP and was 97% (95% confidence interval, 79 to 100) for diphtheria-tetanus toxoids-whole cell pertussis vaccine. Adjustment for potentially confounding variables did not change the results significantly. CONCLUSIONS: Three doses of the two-component acellular pertussis vaccine protected infants against pertussis disease during the period before the recommended booster vaccination. For typical pertussis disease as defined by the WHO efficacy was high and similar to that of a licensed German diphtheria-tetanus toxoids-whole cell pertussis vaccine. 相似文献